Please Wait
Applying Filters...
menu
    • menu
    FDA approvals drop 8% in 2025, with fewer blockbusters; Brinsupri, Rhapsido make it to first-in-class list

    Data Compilation
    #PharmaFlow

    Pipeline Prospector February 2026 highlights: Gilead buys Arcellx for US$ 7.8 bn; FDA okays Vanda’s psychotic pill

    Stock Recap
    #PipelineProspector

    Menu

    Nitroxoline

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    MARKET PLACE

    PharmaCompass
    $ API Ref.Price (USD/KG) : 156Xls download

    Filters

    clear-filterReset all filters
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    Log in to download the data

    Last Updated on PharmaCompass Virtual Booth Country Name of the Firm Written Confirmation No. Product Name Issue Date Valid Till Address of the Firm
    06/02/2026 Aparna Pharmaceuticals
    India
    		 M/s Aparna Pharmaceuticals Pvt ltd WC-0460 Nitroxoline IH 2024-03-21 2027-03-20 Sy. No. 78, 79, 80 & 145, Chittivalasa Village,Padibhimavaram (Panchayat), Ranastalam (M),Srikakulam District, Andhra Pradesh, India
    04/06/2025 Kopran
    India
    		 M/s Kopran Research Laboratories Limited WC-0090 Nitroxoline IH 2022-08-31 2025-07-14 MIs Kopran Research Laboratories Limited, K-4/4, Additional MIDC, Birwadi, Mahad - 402302, Taluka: Mahad, District Raigad
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.